Henry Schein, Inc. (NASDAQ:HSIC) Position Reduced by Centerstone Investors LLC

Centerstone Investors LLC decreased its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 27.2% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 51,991 shares of the company's stock after selling 19,383 shares during the period. Henry Schein makes up approximately 5.3% of Centerstone Investors LLC's investment portfolio, making the stock its 6th largest holding. Centerstone Investors LLC's holdings in Henry Schein were worth $3,598,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Invesco Ltd. grew its stake in Henry Schein by 0.4% during the 4th quarter. Invesco Ltd. now owns 4,963,409 shares of the company's stock valued at $343,468,000 after purchasing an additional 17,552 shares during the last quarter. FMR LLC boosted its position in Henry Schein by 6.6% in the fourth quarter. FMR LLC now owns 3,498,033 shares of the company's stock valued at $242,064,000 after buying an additional 217,143 shares during the last quarter. Geode Capital Management LLC increased its holdings in Henry Schein by 0.5% in the 4th quarter. Geode Capital Management LLC now owns 3,169,033 shares of the company's stock worth $218,762,000 after buying an additional 14,876 shares during the period. Palestra Capital Management LLC purchased a new position in Henry Schein during the 4th quarter worth approximately $182,988,000. Finally, Fiduciary Management Inc. WI lifted its stake in Henry Schein by 7.2% during the 4th quarter. Fiduciary Management Inc. WI now owns 2,488,335 shares of the company's stock valued at $172,193,000 after acquiring an additional 167,990 shares during the period. Institutional investors and hedge funds own 96.62% of the company's stock.

Insider Buying and Selling at Henry Schein

In related news, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the transaction, the chief executive officer now directly owns 62,688 shares in the company, valued at approximately $4,460,251.20. This represents a 6.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Philip A. Laskawy sold 2,604 shares of the company's stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the transaction, the director now directly owns 24,805 shares of the company's stock, valued at approximately $1,762,147.20. This represents a 9.50% decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is owned by insiders.

Henry Schein Price Performance

Shares of Henry Schein stock traded down $0.11 on Wednesday, hitting $73.55. The company's stock had a trading volume of 279,055 shares, compared to its average volume of 1,657,699. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The firm has a fifty day moving average price of $67.54 and a 200-day moving average price of $71.58. Henry Schein, Inc. has a 52-week low of $60.56 and a 52-week high of $82.49. The company has a market capitalization of $8.95 billion, a P/E ratio of 30.29, a price-to-earnings-growth ratio of 2.13 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings results on Monday, May 5th. The company reported $1.15 EPS for the quarter, beating the consensus estimate of $1.11 by $0.04. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. During the same period in the prior year, the business earned $1.10 earnings per share. The company's quarterly revenue was down .1% on a year-over-year basis. On average, equities research analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on HSIC. UBS Group reduced their target price on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a report on Wednesday, February 26th. Wall Street Zen lowered Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday, April 17th. Piper Sandler lowered their target price on Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 30th. Barrington Research dropped their target price on Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a report on Tuesday, May 6th. Finally, Wells Fargo & Company decreased their price target on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a report on Tuesday, May 6th. Six equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $79.30.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.